Clinical Trials Directory

Trials / Completed

CompletedNCT06904612

Using Iodized Salt to Improve Serum Folate, B12 and Iron Levels

Micronutrient-fortified Iodized Salt and Serum Concentrations of Folate, B12 and Iron in Reproductive-aged Women of Rural India

Status
Completed
Phase
Study type
Observational
Enrollment
200 (actual)
Sponsor
Hydrocephalus and Neuroscience Institute · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

Question: How effective is fortified iodized salt in increasing serum concentrations of folate, B12 and iron among non-pregnant and non-lactating women of reproductive age? Hypothesis: Micronutrient fortified iodized salt can increase serum levels (of folate, B12 and iron) and serve as a policy consideration in salt fortification with both iodine and other micronutrients to reduce serious and fatal birth defects.

Detailed description

Salt is an ideal vehicle for fortification because its universal consumption and often centrally processed with established distribution channels. Over 70% of households globally have access to iodized salt. Considering the success of salt iodization, it is logical to use the existing infrastructure to provide folic acid and other micronutrients (such as B12 and iron) through this dietary mechanism. AIM:To assess increase in blood concentrations of folate, B12 and iron among women of reproductive age who consume micronutrient-fortified iodized salt for 3 months. OBJECTIVES : 1. To examine the effect of consumption of iodized salt fortified with folic acid, B12 and iron on serum/plasma concentrations among women of reproductive age. 2. To assess acceptance of study salt for daily use during 3 months of consumption.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMicronutrient fortified iodized saltaddition of folic acid, B12 and iron to iodized salt to be consumed daily and assess rise in serum levels.

Timeline

Start date
2022-06-01
Primary completion
2022-11-30
Completion
2022-11-30
First posted
2025-04-01
Last updated
2025-07-14

Locations

2 sites across 2 countries: United States, India

Source: ClinicalTrials.gov record NCT06904612. Inclusion in this directory is not an endorsement.